Women and Coronary Artery Disease

Clinical Trial Finder

Many women with coronary artery disease are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Pulmonary Vascular Disease Phenomics Program PVDOMICS

Condition:   Pulmonary Arterial Hypertension
Intervention:   Other: No Intervention
Sponsors:   The Cleveland Clinic;   Brigham and Women's Hospital;   Columbia University;   Weill Medical College of Cornell University;   Johns Hopkins University;   Mayo Clinic;   University of Arizona;   Vanderbilt University
Recruiting - verified December 2016

Comprehensive Treatment of Angina in Women With Microvascular Dysfunction

Conditions:   Angina Pectoris;   Coronary Microvascular Disease
Interventions:   Dietary Supplement: Diet;   Behavioral: Training;   Drug: Medication (with statin and ACE-inhibition)
Sponsors:   Bispebjerg Hospital;   University Hospital Bispebjerg and Frederiksberg;   Cambridge Weight Plan Limited
Not yet recruiting - verified November 2016

Household Air Pollution and Health: A Multi-country LPG Intervention Trial

Condition:   Infant, Low Birth Weight
Intervention:   Other: Liquefied petroleum gas (LPG) cookstove
Sponsors:   Emory University;   National Institutes of Health (NIH);   National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting - verified November 2016

Paced Electrocardiogram Requiring Fast Emergent Coronary Therapy (PERFECT) Study

Condition:   Acute Myocardial Infarction
Sponsor:   Hennepin County Medical Center, Minneapolis
Recruiting - verified November 2016

Inorganic Nitrite Delivery to Improve Exercise Capacity in HFpEF

Condition:   Heart Failure
Interventions:   Drug: Nebulized Sodium Nitrite;   Drug: Placebo
Sponsors:   Adrian Hernandez;   National Heart, Lung, and Blood Institute (NHLBI);   Aires Pharmaceuticals, Inc.;   University of Vermont;   Université de Montréal;   Mayo Clinic;   Massachusetts General Hospital
Recruiting - verified November 2016

A Study of the ReCor Medical Paradise System in Clinical Hypertension

Conditions:   Hypertension;   Vascular Diseases
Interventions:   Device: The Paradise® Renal Denervation Ultrasound System;   Device: Sham Procedure
Sponsor:   ReCor Medical, Inc.
Recruiting - verified July 2016

Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia

Condition:   Eligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD)
Interventions:   Drug: Epanova® (omega-3 carboxylic acids);   Drug: corn oil control
Sponsors:   AstraZeneca;   Cleveland Clinic Coordinating Center for Clinical Research (C5R);   Quintiles, Inc.
Recruiting - verified November 2016

A Study Comparing Cardiovascular Effects of Ticagrelor Versus Placebo in Patients With Type 2 Diabetes Mellitus

Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: Ticagrelor 60 mg;   Drug: Ticagrelor placebo
Sponsor:   AstraZeneca
Active, not recruiting - verified November 2016

Cardiovascular Inflammation Reduction Trial

Condition:   Cardiovascular Disease
Interventions:   Drug: Methotrexate;   Drug: Placebo
Sponsors:   Brigham and Women's Hospital;   National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified November 2016